Grassley Stumbles In Comments On Meridia’s Regulatory History
This article was originally published in The Pink Sheet Daily
Executive Summary
Finance Committee chair criticizes lack of action on the obesity agent, but Abbott revised the product’s risk management plan nearly a year ago.